AT298691B - Verfahren zur Herstellung von neuen 6,7-disubstituierten Östratrienen - Google Patents

Verfahren zur Herstellung von neuen 6,7-disubstituierten Östratrienen

Info

Publication number
AT298691B
AT298691B AT105970A AT105970A AT298691B AT 298691 B AT298691 B AT 298691B AT 105970 A AT105970 A AT 105970A AT 105970 A AT105970 A AT 105970A AT 298691 B AT298691 B AT 298691B
Authority
AT
Austria
Prior art keywords
estatrienes
disubstituted
preparation
new
disubstituted estatrienes
Prior art date
Application number
AT105970A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of AT298691B publication Critical patent/AT298691B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT105970A 1969-02-06 1970-02-05 Verfahren zur Herstellung von neuen 6,7-disubstituierten Östratrienen AT298691B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691906716 DE1906716A1 (de) 1969-02-06 1969-02-06 6,7-Disubstituierte OEstratriene

Publications (1)

Publication Number Publication Date
AT298691B true AT298691B (de) 1972-05-25

Family

ID=5724891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT105970A AT298691B (de) 1969-02-06 1970-02-05 Verfahren zur Herstellung von neuen 6,7-disubstituierten Östratrienen

Country Status (8)

Country Link
JP (1) JPS4945866B1 (de)
AT (1) AT298691B (de)
BE (1) BE745612A (de)
CH (2) CH543493A (de)
DE (1) DE1906716A1 (de)
FR (1) FR2034525A1 (de)
GB (1) GB1304263A (de)
NL (1) NL7001756A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10174070B2 (en) * 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use

Also Published As

Publication number Publication date
JPS4945866B1 (de) 1974-12-06
NL7001756A (de) 1970-08-10
FR2034525A1 (fr) 1970-12-11
GB1304263A (de) 1973-01-24
CH539622A (de) 1973-07-31
CH543493A (de) 1973-12-14
BE745612A (fr) 1970-08-06
DE1906716A1 (de) 1970-08-20

Similar Documents

Publication Publication Date Title
AT319948B (de) Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
AT301545B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinen
AT298452B (de) Verfahren zur Herstellung von neuen Aminoalkylphenolen
AT299924B (de) Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT313292B (de) Verfahren zur Herstellung von neuen 4-heterosubstituierten Azetidinonen-(2)
AT295547B (de) Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen
AT299456B (de) Verfahren zur Herstellung von neuen Δ<4,20,22>-Bufatrienolidrhamnosidäthern
AT312606B (de) Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden
AT307624B (de) Verfahren zur Herstellung von neuen Purinribofuranosid-3',5'-cyclophosphaten
AT304497B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-äthano-anthrazenen
AT299925B (de) Verfahren zur Herstellung von neuen 1-Amino-anthrachinonen
AT296333B (de) Verfahren zur Herstellung von neuen 4-Oxaphosphorinanen
AT296300B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-5,6-dihydro-4H-pyranen
AT299952B (de) Verfahren zur Herstellung von neuen substituierten 2-Azabicycloalkanen
AT304500B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-ätheno-anthracenen
AT298691B (de) Verfahren zur Herstellung von neuen 6,7-disubstituierten Östratrienen
AT300206B (de) Verfahren zur Herstellung von neuen 6,7-Benzomorphanen
AT290543B (de) Verfahren zur Herstellung von neuen 3-Aryl-azo-4,5-dihalogenpyridazonen-(6)
AT320868B (de) Verfahren zur Herstellung von neuen Cardenolid-3-[2',3'-didesoxyglykosiden]
AT306252B (de) Verfahren zur Herstellung von neuen 2,3-Alkylidenrhamnopyranosiden
AT299946B (de) Verfahren zur Herstellung von neuen 1,3-Benzodioxol-2-thionen
CH536319A (de) Verfahren zur Herstellung von neuen 10-Piperazino-10,11-dihydrodibenzo-(b,f)-thiepinen
CH526548A (de) Verfahren zur Herstellung von neuen Derivaten von 1,2,3,4-Tetrahydroisochinolin
AT293375B (de) Verfahren zur Herstellung von neuen 3-Acylamino-pyrrolidindion-(2,4)-Verbindungen
AT305268B (de) Verfahren zur Herstellung von neuen 9,10-Dihydro-9,10-äthano-anthracenen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee